Literature DB >> 12657434

Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease.

Ari Barzilai1, Eldad Melamed.   

Abstract

Parkinson's disease (PD) is a progressive neurological disease caused by selective degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNc). Although PD has been heavily researched, the precise etiology of nigral cell loss is still unknown and, consequently, treatment is largely symptomatic rather than preventive. There are conflicting data regarding the mode of dopaminergic cell death in PD and, hence, this remains controversial. Several mutations in specific genes have recently been linked with hereditary forms of PD. Although none of these mutations are seen in idiopathic disease cases, the elucidation of these genetic defects sheds light on the nature of idiopathic PD. It is possible that dopaminergic neurogenesis also contributes to the etiology of idiopathic PD. In addition, intracellular as well as extracellular substances found in the SNc are believed to function as damaging pathogenetic factors. These factors, and the interactions among them, might hold the secret to the underlying causes of the selective death of dopaminergic neurons in PD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657434     DOI: 10.1016/s1471-4914(03)00020-0

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  42 in total

1.  Expression and function of dopamine receptors in the developing medial frontal cortex and striatum of the rat.

Authors:  S E Sillivan; C Konradi
Journal:  Neuroscience       Date:  2011-10-08       Impact factor: 3.590

2.  Pathophysiology of manganese-associated neurotoxicity.

Authors:  Brad A Racette; Michael Aschner; Tomas R Guilarte; Ulrike Dydak; Susan R Criswell; Wei Zheng
Journal:  Neurotoxicology       Date:  2011-12-21       Impact factor: 4.294

3.  Neuroprotective Effects of Filgrastim in Rotenone-Induced Parkinson's Disease in Rats: Insights into its Anti-Inflammatory, Neurotrophic, and Antiapoptotic Effects.

Authors:  Mariama S Azmy; Esther T Menze; Reem N El-Naga; Mariane G Tadros
Journal:  Mol Neurobiol       Date:  2018-01-11       Impact factor: 5.590

4.  Neuroprotective effects of active ingredients isolated from Pegasus laternarius on cultured cerebral neurons.

Authors:  Mengtao Li; Minhui Chen; Hai Huang; Wucheng Tao; Jihong Cui; Hui Xiang
Journal:  Cell Mol Neurobiol       Date:  2010-08-24       Impact factor: 5.046

Review 5.  Class II G protein-coupled receptors and their ligands in neuronal function and protection.

Authors:  Bronwen Martin; Rakel Lopez de Maturana; Randall Brenneman; Tom Walent; Mark P Mattson; Stuart Maudsley
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

6.  Do polymorphisms in transcription factors LMX1A and LMX1B influence the risk for Parkinson's disease?

Authors:  Olle Bergman; Anna Håkansson; Lars Westberg; Andrea Carmine Belin; Olof Sydow; Lars Olson; Björn Holmberg; Laura Fratiglioni; Lars Bäckman; Elias Eriksson; Hans Nissbrandt
Journal:  J Neural Transm (Vienna)       Date:  2009-02-03       Impact factor: 3.575

7.  Ribosylation rapidly induces alpha-synuclein to form highly cytotoxic molten globules of advanced glycation end products.

Authors:  Lan Chen; Yan Wei; Xueqing Wang; Rongqiao He
Journal:  PLoS One       Date:  2010-02-04       Impact factor: 3.240

8.  Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans.

Authors:  Alexandre Benedetto; Catherine Au; Daiana Silva Avila; Dejan Milatovic; Michael Aschner
Journal:  PLoS Genet       Date:  2010-08-26       Impact factor: 5.917

9.  Decreased NURR1 gene expression in patients with Parkinson's disease.

Authors:  Weidong Le; Tianhong Pan; Maosheng Huang; Pingyi Xu; Wenjie Xie; Wen Zhu; Xiong Zhang; Hao Deng; Joseph Jankovic
Journal:  J Neurol Sci       Date:  2008-08-05       Impact factor: 3.181

10.  Genome-wide microarray analysis of the differential neuroprotective effects of antioxidants in neuroblastoma cells overexpressing the familial Parkinson's disease alpha-synuclein A53T mutation.

Authors:  Lei Ma; Tracy T Cao; Geeta Kandpal; Lee Warren; J Fred Hess; Guy R Seabrook; William J Ray
Journal:  Neurochem Res       Date:  2009-08-02       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.